Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Form 8.5 (EPT/RI)

25 May 2023 08:59

RNS Number : 6533A
Liberum Capital Limited
25 May 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Civitas Social Housing Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Civitas Social Housing Plc

(d) Date dealing undertaken:

24th May 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1p

 

Purchase

 

194,937

 

0.7983

 

0.79801

 

 

ORD 1p

 

 

Sale

 

249,262

 

0.7985

 

0.798

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

25th May 2023

Contact name:

Kathryn Saunders

Telephone number:

020 3100 2048

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGRGDUXUDDGXU
Date   Source Headline
13th May 202112:36 pmRNSIssue of Equity
12th May 20215:59 pmRNSIssue of Equity
11th May 20217:00 amRNSNet Asset Value, Trading and Market Update
27th Apr 20217:00 amRNS£10.9million acquisition
1st Apr 20213:30 pmRNSTotal Voting Rights
24th Mar 20213:51 pmRNSIssue of Equity
18th Mar 202110:06 amRNSResponse to Hilldale and Pivotal Judgements
12th Mar 202110:37 amRNSResponse to RSH
9th Mar 20211:26 pmRNSQuotedData’s Real Estate Roundup – March 2021
3rd Mar 202111:10 amRNSFitch Assigns Civitas an Investment Grade Rating
19th Feb 20217:00 amRNS£84.5m Seven Year Term Facility with M&G
12th Feb 202111:00 amRNSResponse to RSH
11th Feb 202110:19 amRNSResponse to RSH
2nd Feb 20217:00 amRNSNet Asset Value, Trading and Market Update
25th Jan 202110:09 amRNSQuotedData’s Real Estate Sector Annual Review
17th Dec 202010:06 amRNSResponse to RSH
30th Nov 20204:41 pmRNSHolding(s) in Company
30th Nov 20207:00 amRNSINTERIM REPORT
18th Nov 20204:02 pmRNSHolding(s) in Company
18th Nov 20203:58 pmRNSHolding(s) in Company
18th Nov 20203:55 pmRNSHolding(s) in Company
18th Nov 20203:50 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSNotice of Half Year Results
10th Nov 20201:40 pmRNSHolding(s) in Company
6th Nov 202011:14 amRNSHolding(s) in Company
6th Nov 20207:00 amRNSNet Asset Value, Trading and Market Update
3rd Nov 20203:37 pmRNSHolding(s) in Company
29th Oct 20202:58 pmRNSHolding(s) in Company
22nd Oct 20201:37 pmRNSUpdate research from QuotedData
13th Oct 20201:32 pmRNSResponse to RSH
11th Sep 202011:31 amRNSReal Estate Roundup Review – September 2020
8th Sep 20205:45 pmRNSResult of AGM
24th Aug 20207:00 amRNSCompletion of New Facilities in Wales
21st Aug 20205:19 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSNotice of Annual General Meeting
6th Aug 20207:00 amRNSNet Asset Value, Trading and Market Update
8th Jul 20204:49 pmRNSHolding(s) in Company
8th Jul 202012:31 pmRNSReal Estate Roundup Review – July 2020
30th Jun 20202:04 pmRNSCORRECTION: Annual Results
30th Jun 20207:00 amRNSAnnual Results
17th Jun 20209:40 amEQSHardman & Co Research: Civitas Investment Management presenting at virtual Investor Forum on 9th July 2020
3rd Jun 20207:00 amRNSNotice of Full Year Results
28th May 202010:43 amRNSResult of General Meeting
11th May 20207:00 amRNSPosting of the Notice of General Meeting
11th May 20207:00 amRNSNet Asset Value, Investment and Market Update
20th Apr 20203:42 pmRNSInvestment Companies Quarterly Roundup
15th Apr 202011:05 amRNSUpdate research from QuotedData
7th Apr 20203:54 pmRNSReal Estate Roundup Review – April 2020
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.